Localized large B-cell lymphoma with MYC and BCL6 rearrangements as an unexpected finding in an appendectomy specimen

被引:0
|
作者
Poltorak, Przemyslaw Marcin [1 ]
Plesner, Trine Lindhardt [2 ]
Petersson, Eva Stampe [2 ]
Schejbel, Lone [3 ]
Breinholt, Marie Fredslund [3 ]
Lode, Lise [4 ]
Hutchings, Martin [5 ]
Norgaard, Peter [1 ]
机构
[1] Univ Copenhagen, Dept Pathol, Hosp Hvidovre, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark
[2] Rigshosp, Copenhagen Univ Hosp, Dept Pathol, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Pathol, Hosp Herlev, Herlev, Denmark
[4] Univ Copenhagen, Surg Sect, Gastrounit, Hosp Hvidovre, Hvidovre, Denmark
[5] Rigshosp, Copenhagen Univ Hosp, Dept Haematol, Copenhagen, Denmark
关键词
Appendix; double-hit lymphoma; HGBL; c-myc; bcl6; HEALTH-ORGANIZATION CLASSIFICATION; OUTCOMES;
D O I
10.1111/apm.13492
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Large B-cell lymphomas (LBLs) comprise a genetically heterogeneous group of clinically aggressive non-Hodgkin lymphomas, frequently exhibiting overlapping features with diffuse large B-cell lymphoma and Burkitt's lymphoma. We report a case of a 24-year-old, previously healthy male with a classical clinical presentation of acute appendicitis. The pathologic examination discovered a large B-cell lymphoma with MYC and BCL6 rearrangements in the excised appendix. The patient was assigned Stage IEA, IPI = 0 and received chemotherapy. This case depicts a very uncommon occurrence of fully localized LBL in a patient of an unusually young age and clinical presentation for this type of lymphoma.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab
    Akyurek, Nalan
    Uner, Aysegul
    Benekli, Mustafa
    Barista, Ibrahim
    CANCER, 2012, 118 (17) : 4173 - 4183
  • [32] The Impact of MYC Rearrangements and "Double Hit" Abnormalities in Diffuse Large B-Cell Lymphoma
    Lin, Pei
    Medeiros, L. Jeffrey
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (03) : 243 - 252
  • [33] Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
    Huang, Sixia
    Nong, Lin
    Wang, Wei
    Liang, Li
    Zheng, Yalin
    Liu, Jumei
    Li, Dong
    Li, Xin
    Zhang, Bo
    Li, Ting
    DIAGNOSTIC PATHOLOGY, 2019, 14 (1)
  • [34] Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?
    Liu, Hui
    Shen, Qi
    Chang, Chung-Che
    Hu, Shimin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [35] Coexistent Rearrangements of c-MYC,BCL2, andBCL6 Genes in a Diffuse Large B-Cell Lymphoma
    Chiyoko Ueda
    Momoko Nishikori
    Toshio Kitawaki
    Takashi Uchiyama
    Hitoshi Ohno
    International Journal of Hematology, 2004, 79 : 52 - 54
  • [36] BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients
    Akay, Olga Me Item
    Aras, Beyhan Durak
    Isiksoy, Serap
    Toprak, Cigdem
    Mutlu, Fezan Sahin
    Artan, Sevilhan
    Oner, Ulku
    Gulbas, Zafer
    CANCER GENETICS, 2014, 207 (03) : 87 - 93
  • [37] Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements
    Ikoma, Haruka
    Miyaoka, Masashi
    Hiraiwa, Shinichiro
    Kikuti, Yara Yukie
    Shiraiwa, Sawako
    Hara, Ryujiro
    Kojima, Minoru
    Ohmachi, Ken
    Ando, Kiyoshi
    Carreras, Joaquim
    Nakamura, Naoya
    PATHOLOGY INTERNATIONAL, 2022, 72 (06) : 321 - 331
  • [38] Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma)
    Zeng, Dongfeng
    Desai, Aakash
    Yan, Fangfang
    Gong, Tiejun
    Ye, Haige
    Ahmed, Makhdum
    Nomie, Krystle
    Romaguera, Jorge
    Champlin, Richard
    Li, Shaoying
    Wang, Michael
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (03): : 304 - 316
  • [39] Alternative genetic alterations of MYC, BCL2, and/or BCL6 in high-grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL): Can we identify different prognostic subgroups?
    Blomme, Siska
    De Paepe, Pascale
    Devos, Helena
    Emmerechts, Jan
    Snauwaert, Sylvia
    Cauwelier, Barbara
    GENES CHROMOSOMES & CANCER, 2024, 63 (01)
  • [40] High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis
    Li, Shaoying
    Weiss, Vivian L.
    Wang, Xuan J.
    Desai, Parth A.
    Hu, Shimin
    Yin, C. Cameron
    Tang, Guilin
    Reddy, Nishitha M.
    Medeiros, L. Jeffrey
    Lin, Pei
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (02) : 253 - 261